Skizofrénia: vizsgálatok itt: Lengyelország
13 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 2026. november 11.. Ask the study team whether a trial fits you.
- 3. fázisTaking peopleA Study to Evaluate the Long-term Safety and Tolerability of Xanomeline and Trospium Chloride for the Treatment of Psychiatric Disorders in Children and Adolescents
- Where
- Gdansk, Katowice, Lublin, Poznan, Szczecin, Warsaw, Wroclaw, Zabrze
- Életkor
- 5 év to 17 év
- People
- 400 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07424404 · EU 2025-524062-16-00 - 3. fázisTaking peopleEvenamide in patients with treatment-resistant schizophrenia not responding to antipsychotics
- Where
- Bialystok, Gdansk, Lodz, Zabrze
- Életkor
- 18 év and over
- People
- 135 worldwide
- Run by
- Newron Pharmaceuticals S.p.A.
See details and how to join2024-519836-18-00 · EU 2024-519836-18-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of ITI-1284 in the Treatment of Psychosis Associated With Alzheimer's Disease
- Where
- Bydgoszcz, Katowice, Ścinawa
- Életkor
- 55 év and over
- People
- 370 worldwide
- Run by
- Intra-Cellular Therapies, Inc.
See details and how to joinNCT06540833 - 3. fázisTaking peopleRelapse Prevention Trial Evaluating KarXT Treatment in Schizophrenia
- Where
- Bialystok, Poznan, Warsaw
- Életkor
- 18 év to 65 év
- People
- 472 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT07686263 · EU 2025-523664-20-00 - 3. fázisTaking peopleA Study to Evaluate KarXT as a Treatment for Psychosis Associated With Alzheimer's Disease (ADEPT-4)
- Where
- Gdansk, Ilawa, Lodz, Lublin, Poznan, Sochaczew
- Életkor
- 55 év to 90 év
- People
- 406 worldwide
- Run by
- Karuna Therapeutics, Inc., a Bristol Myers Squibb company
See details and how to joinNCT06585787 · EU 2024-516363-92-00 - 2. fázisTaking peopleA Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease Psychosis
- Where
- Gdansk, Krakow, Lublin, Plewiska, Poznan, Warszawa
- Életkor
- 55 év to 90 év
- People
- 300 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT06887192 · EU 2024-519820-26-00 - 2. fázisTaking peopleA Clinical trial to evaluate the efficacy of vafidemstat in negative symptoms and cognitive impairment associated with schizophrenia. (EVOLUTION study)
- Where
- Gdansk, Lublin, Olkusz, Poznan, Zabrze
- Életkor
- 18 év to 64 év
- People
- 239 worldwide
- Run by
- Oryzon Genomics S.A.
See details and how to join2023-507372-42-00 · EU 2023-507372-42-00 - No phaseNot yet taking people in LengyelországBasal Stimulation Therapy in Adults With Schizophrenia Requiring Institutional Care
- Where
- Katowice, Rybnik
- Életkor
- 55 év and over
- People
- 12
- Run by
- The Jerzy Kukuczka Academy of Physical Education in Katowice
See details and how to joinNCT07769749 - 2. fázisCsak meghívásosAn Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease Psychosis
- Where
- Gdansk, Krakow, Plewiska, Poznan, Warsaw
- Életkor
- 55 év to 91 év
- People
- 210 worldwide
- Run by
- MapLight Therapeutics
See details and how to joinNCT07459660 · EU 2025-521757-16-00 - No phaseNot yet taking people in LengyelországSnoezelen Therapy in Adults With Alcohol Dependence and Adults With Schizophrenia
- Where
- Katowice, Rybnik
- Életkor
- 18 év and over
- People
- 140
- Run by
- The Jerzy Kukuczka Academy of Physical Education in Katowice
See details and how to joinNCT07748078 - 2. fázisTaking peopleEvaluation of NBI-1117570 in Inpatient Adults With Schizophrenia
- Where
- Bialystok, Gdansk, Lodz, Poznan
- Életkor
- 18 év to 55 év
- People
- 120 worldwide
- Run by
- Neurocrine Biosciences
See details and how to joinNCT07288333 · EU 2025-521868-35-00 - No phaseCsak meghívásosEffects of Transcranial Direct Current Stimulation on Cognitive Rehabilitation in Schizophrenia
- Where
- Lodz
- Életkor
- 18 év to 65 év
- People
- 120
- Run by
- Medical University of Lodz
See details and how to joinNCT07273175 - 2/3. fázisTaking peopleAn Adaptive Phase II/III, Two-Part, Double-Blind, Randomized, Placebo-controlled, Dose-Finding, Multi-center Study of the Safety and Efficacy of NaBen®, as an Add-on Therapy With Clozapine, for Residual Symptoms of Refractory Schizophrenia in Adults
- Where
- Gdansk, Gdańsk, Lublin, Wroclaw
- Életkor
- 18 év to 55 év
- People
- 287 worldwide
- Run by
- SyneuRx International (Taiwan) Corp
See details and how to joinNCT03094429 · EU 2024-519237-34-00